A formulary shift at renewal can turn a stable benefit into an employee disruption. Washington employers need to measure more than the plan’s headline premium before accepting that change.

Request a prescription formulary plan review before renewal.

The practical question is whether a proposed formulary protects employees from avoidable disruption while giving leadership a clear view of renewal costs. The Prescription formulary changes employer health plan review framework organizes that decision around evidence, employee impact, and accountable questions for carriers and PBMs. Here’s how.

Prescription formulary changes employer health plan review framework

At renewal, HR and finance leaders should ask what changed, who may be affected, and how the proposal alters total plan risk. A sound review does not accept the premium quote or projected pharmacy savings as the full business case.

Formularies are tools for managing pharmacy benefits, but cost control must remain balanced with clinical needs. Research on formulary systems notes their role in controlling pharmacy benefits while maintaining access to approved medications. That makes due diligence both a financial review and an employee access review.

Baseline and change inventory

Start with the current formulary, recent pharmacy claims, and the proposed formulary shown side by side. Separate changes to covered drugs, tiers, copays, prior authorization, step therapy, quantity limits, and specialty pharmacy rules. Then compare each change with the drugs employees currently use.

Ask the carrier or PBM for a clear change file, not just a summary. The file should show each affected drug, its new status, covered options, and expected member cost. This detail supports better decisions when managing pharmacy benefits.

• List drugs moving to a higher cost tier.
• Flag drugs removed from coverage.
• Note new prior authorization or step therapy rules.
• Separate specialty drug changes from routine prescriptions.
• Check whether covered alternatives meet common employee needs.

Employee and financial impact

Review both employer spend and employee out-of-pocket exposure. A lower plan cost may shift more expense or effort to people who need ongoing treatment. Higher out-of-pocket prescription costs are linked with lower medication adherence, according to CDC research on employer-sponsored coverage.

Model several outcomes instead of relying on one savings estimate. Include expected pharmacy spend, possible medical cost effects, member copays, and the number of affected employees. For each major change, ask how an employee can seek an exception or switch drugs.

• Estimate total plan cost under current and proposed rules.
• Measure the cost shift to employees and dependents.
• Review disruption among high-use and high-cost claim groups.
• Confirm the transition, exception, and appeal process.

Decision record and renewal terms

Turn the review into a short decision record for leaders. Show the change, expected savings, employee impact, access safeguards, and remaining uncertainty. This record makes evaluating plan changes at renewal more consistent and easier to explain.

Request written answers for any unclear PBM assumptions. Confirm when the formulary may change again, how notice will reach members, and what reporting the employer will receive. Approve the proposal only when the cost case, access plan, and employee communication plan work together.

What should employers compare between formularies?

Employers should compare drug coverage, tiers, member costs, prior authorization, step therapy, quantity limits, specialty pharmacy rules, and exception processes. The most useful comparison connects each change to de-identified claims so leaders can see how many employees may face higher costs. New administrative steps, or a change in covered treatment.

Start with the drugs employees use

Compare the current and proposed formularies against recent pharmacy claims, one drug at a time. Focus first on medicines used often, high-cost drugs, and treatments with no simple substitute. This review makes prescription formulary changes in an employer health plan concrete.

For each drug, record its coverage status, tier, member cost, and any access rule. Higher out-of-pocket costs are linked with lower medication adherence, according to a CDC study of employer-sponsored coverage. A lower premium can hide added costs or disruption for employees.

Build a side-by-side comparison

Use the same fields for both formularies. Mark every change, then ask the carrier or PBM to explain the reason and available alternatives. This approach adds needed detail when reviewing large-group health plan options.

Comparison item	Current formulary	Proposed formulary	Employer review question
Coverage and exclusions	Covered or excluded	Covered or excluded	Which used drugs lose coverage?
Tier and member cost	Current tier and cost share	New tier and cost share	Who may pay more?
Prior authorization	Current approval rule	New approval rule	Which drugs need new approval?
Step therapy and limits	Current steps and quantity limits	New steps and quantity limits	Will access take longer?
Specialty pharmacy rules	Current pharmacy and handling rules	New pharmacy and handling rules	Must employees change pharmacies?
Transition provisions	Current refill protections	Temporary coverage and exception process	How will ongoing treatment continue?

Do not treat a move between tiers as a minor edit. It may change the employee’s cost even when the drug remains covered. An exclusion, new approval rule, or required specialty pharmacy can cause greater disruption.

Test access before renewal

Ask the PBM for a disruption report that matches employee claims to the proposed formulary. The report should show affected drugs, members, projected cost changes, and covered alternatives. It should also separate routine prescriptions from specialty treatments.

Next, review how prior authorization, step therapy, quantity limits, and exceptions work in practice. Confirm who handles requests, what records are needed, and how employees receive updates. Clear answers support better decisions when managing pharmacy benefits.

Finally, examine transition provisions for people already taking an affected drug. Ask whether temporary fills are allowed and when employees must request an exception. Compare these protections alongside expected plan costs, since access and cost predictability both matter.

How can employers measure employee disruption?

Employers can measure disruption by matching proposed drug-level changes to de-identified claims, then scoring how many people may face exclusions, tier changes, new approvals, or limited alternatives. The review should also estimate changes in employee cost, identify high-impact ongoing therapies, and document the support available before the new plan year.

Employers can measure disruption by comparing the current formulary with the proposed formulary before renewal. The review should connect drug-level changes to de-identified claims while keeping personal health details out of employer reports.

Build a privacy-conscious baseline

Start by asking the carrier or pharmacy benefit manager for an aggregate utilization report. It should show drug categories, current tiers, claim counts, total allowed costs, and member cost-sharing without names or member IDs.

Ask the vendor to suppress small groups of claims that could reveal a person’s identity. The vendor’s privacy and legal teams should set the right reporting threshold for the group’s size and data rules.

• Separate maintenance, preventive, acute, and specialty drug categories.
• Flag drugs that may move tiers, require prior authorization, or leave the formulary.
• Show affected claim counts and de-identified member counts as separate measures.
• Compare current cost-sharing with proposed cost-sharing by drug category.

Measure the likely member impact

Member disruption is broader than a drug losing coverage. A tier change, new step therapy rule, or higher cost share can also affect access and adherence. The CDC links higher prescription out-of-pocket costs with lower adherence, so employee cost exposure deserves a clear place in the review.

Use a simple impact scale for each proposed change. A low-impact change may affect few claims and offer a close alternative. A high-impact change may affect ongoing therapy, specialty medication, or many repeat claims.

• Count people with at least one affected claim, using de-identified totals.
• Estimate how many current claims would face a tier or rule change.
• List available alternatives without assuming they are suitable for each person.
• Note where employees may need help from the carrier, PBM, or prescriber.

This analysis also helps employers ask sharper questions about managing pharmacy benefits. The goal is to find where a plan change may create friction, not to review any employee’s treatment.

Report scenarios, not promises

Present the findings as a range of possible outcomes. Show the share of de-identified members and claims touched by each scenario, along with the type of action each change may require.

Keep coverage and savings language conditional. A disruption report cannot confirm that an alternative drug will work, that an exception will be approved, or that projected costs will occur.

Use the findings when evaluating plan changes at renewal. Employers can then weigh cost predictability against employee access, communication needs, and the work required to support affected members.

Renewal checklist for formulary due diligence

A careful renewal review should connect drug access, employee cost, and total plan spend. Use this sequence before accepting prescription formulary changes in an employer health plan. Ask the carrier, broker, and PBM to answer each question in writing.

Documents and change details

Start with the current formulary, proposed formulary, and a clear change report. Formularies are core tools for managing pharmacy benefits, so details matter. Research on their development shows that these systems help control benefits while supporting clinical effectiveness. Review the history and purpose of formulary systems for useful context.

1. Request a complete change file. Which drugs will be added, removed, moved to another tier, or placed behind new controls? Ask for both drug names and National Drug Codes. Require the effective date and the reason for every change.

2. Measure the member effect. How many employees or dependents used each affected drug during the review period? What will each person pay under the proposed terms? Ask for a list of available alternatives and their expected member costs.

3. Test the exception process. What must a member and prescriber submit when a covered drug changes? Ask about review times, urgent requests, appeals, and temporary fills. Confirm who helps members when an exception is denied or delayed.

4. Review specialty drug rules. Which specialty drugs drive the most gross and net spend? Ask about prior authorization, preferred pharmacies, site-of-care rules, and manufacturer assistance. Require separate reporting for rebates, fees, and member cost.

5. Reconcile every price component. What are the ingredient cost, dispensing fee, rebate, spread, and PBM fee for major drugs? Request guarantees in contract language, not only presentation slides. Compare estimates under both the current and proposed formulary.

6. Set reporting and support terms. Which reports will HR and finance receive, and how often? Name the team responsible for employee notices, questions, and escalations. Set service standards and a schedule for checking results after renewal.

Cost, access, and accountability

Do not judge a proposal by premium impact or rebate totals alone. Higher out-of-pocket drug costs are linked with lower medication adherence among people with employer-sponsored coverage. The CDC study on drug costs and adherence shows why member impact belongs in the renewal review.

Ask for net plan cost, employee cost, and access measures in one report. Then assign an owner and due date to each open question. A structured approach to evaluating plan changes at renewal helps leaders compare tradeoffs and track unresolved terms before signing.

Finally, require a post-renewal review that uses the same measures promised during bidding. Track denied claims, exceptions, specialty spend, member complaints, and net pharmacy cost. Consistent reporting makes it easier to spot gaps early and hold each partner to its commitments.

How do formulary changes affect total plan cost?

Formulary changes can alter the employer’s premium and pharmacy spending while also shifting costs to employees. A complete review compares projected claims, rebates, vendor fees, specialty drug rules, and member cost sharing. Leaders should judge the combined effect rather than treating a lower premium as proof of a lower overall cost.

When reviewing prescription formulary changes, employer health plan costs require more than a premium comparison. A lower premium may come with higher drug copays, tighter coverage rules, or more employee cost exposure.

Premiums and pharmacy spending

Start with the employer’s full cost, not the renewal rate alone. Review premiums, expected pharmacy claims, employer health savings account funding, and any separate pharmacy fees. This wider view helps reveal costs that a premium-only comparison can hide.

Ask the carrier or pharmacy benefit manager to show how each formulary change affects projected spending. The review should separate drug cost changes from changes in rebates, fees, and employee cost sharing. Clear reporting supports prescription cost transparency and makes tradeoffs easier to assess.

• Employer premium contributions and expected claims
• Pharmacy benefit manager and specialty drug fees
• Employer-funded accounts or reimbursement support
• Estimated employee copays, coinsurance, and deductibles

Employee cost and access

A formulary change can shift cost from the plan to employees without reducing the combined cost of care. Review which drugs move to higher tiers, lose coverage, or gain prior authorization rules. Also check whether covered alternatives meet the needs of affected employees.

Employee cost exposure matters because higher prescription costs can change how people use their medication. A CDC study of employer-sponsored coverage linked higher out-of-pocket costs with lower adherence to blood pressure medication. Employers should account for that risk when weighing short-term pharmacy savings.

A side-by-side cost review

Compare each option under the same use assumptions. Use recent pharmacy claims when available, then model how current prescriptions would be covered under each proposed formulary. Pay close attention to high-use drugs, specialty drugs, exclusions, and large tier changes.

A useful comparison also flags costs that projections may not capture well. These may include employee appeals, drug substitutions, extra benefit questions, and treatment delays. The aim is not to assign a dollar value to every issue. It is to make the full set of tradeoffs clear before selection.

Then test more than one likely outcome. A base case shows expected costs, while higher-use and specialty-drug cases reveal possible budget pressure. This approach supports cost predictability without claiming that any single plan will always cost less.

The final review should show employer cost, employee cost, and access effects on one page. It should also state which assumptions could change. Employers can use that summary when evaluating plan changes at renewal and explaining the decision to employees.

Talk with a Washington benefits advisor about formulary renewal due diligence.

Communicate formulary changes before they become problems

Prescription formulary changes can affect an employee’s cost, pharmacy steps, or access to a current drug. A clear plan gives people time to review options before coverage changes.

Start communication while evaluating plan changes at renewal, then repeat the key details before the effective date. Early notice also gives HR time to test each support path.

A two-stage notice plan

Send the first notice before employees choose plans. Explain which formulary will apply, where to search it, and how to compare drug costs. State that covered drugs, tiers, and approval rules may differ between plan options.

Send a shorter reminder before the effective date. Include the new formulary link, member service number, and clear steps for questions. Ask the carrier or PBM to confirm when its online search tool reflects the new plan year.

• Tell all eligible employees where to review the new formulary and plan materials.
• Have the carrier or PBM send targeted notices to affected members when possible.
• Give managers a short script that routes questions to benefits support, not workplace discussion.

Clear action paths for affected employees

Each notice should answer one practical question: what should an employee do if a current prescription changes? Direct them to check coverage, contact the carrier or PBM, and speak with their prescriber about covered options.

Explain where employees can ask about prior approval, step therapy, exceptions, or appeals. If the renewal also changes medical networks, give employees access to WHIA’s provider search resources so they can review doctors and facilities alongside prescription coverage. Employers reviewing their support model should also understand how their partner is managing pharmacy benefits and handling member questions.

Cost details matter because higher out-of-pocket costs are linked with lower use of prescribed blood pressure drugs. This CDC study on medication adherence supports giving employees a simple way to check costs before filling a prescription.

Privacy-conscious escalation support

Employees should not need to tell HR which drugs they take. Notices should direct personal medication questions to the carrier, PBM, or a named benefits advocate. HR can still track patterns, such as long wait times, without collecting personal health details.

Create an escalation path before notices go out. Name the first contact, the backup contact, and the expected response time. If a case remains unresolved, the benefits advisor can help coordinate with the plan while the employee works with their prescriber.

Keep messages easy to find after enrollment. Store the notices, links, phone numbers, and escalation steps in the benefits portal. Consistent guidance helps employees act early and helps employers spot service gaps before they grow.

Make a defensible renewal decision

A sound renewal decision weighs more than the new premium. Employers should compare cost, employee disruption, administrative work, and access to needed drugs. The goal is a choice that leaders can explain and the benefits team can carry out.

A balanced decision record

Start with a short decision record that lists each option and the tradeoffs reviewed. Include the total plan cost, employee cost sharing, key formulary changes, and expected administrative effort. This record helps leaders compare options on the same terms rather than focus on one appealing number.

Give employee impact its own place in the review. Higher prescription costs can reduce medication adherence, according to a CDC study of people with employer-sponsored insurance. Note which drug changes could disrupt care, how many members may be affected, and what support is available.

• Cost: premiums, prescription cost sharing, and likely plan spending
• Disruption: removed drugs, new tiers, and added approval rules
• Administration: notices, enrollment materials, and employee questions
• Advocacy: help with alternatives, exceptions, and coverage issues

Clear reasons for the final choice

Document why the selected option offers the best overall fit for the organization. Also record why other options were not chosen. When reviewing prescription formulary changes, an employer health plan decision should state which tradeoffs were accepted and which risks need follow-up.

Pair that record with an action plan. Assign owners for employee notices, carrier questions, appeals support, and early claims review. A broader framework for evaluating plan changes at renewal can help keep pharmacy decisions tied to the full benefits strategy.

Support after the decision

The work continues after leaders sign off. Benefits teams should prepare plain-language notices before enrollment and give employees a clear place to ask for help. They should also track access problems after the new plan starts, then raise patterns with the carrier or PBM.

Washington Health Insurance Agency can provide unbiased guidance while employers compare the choices. Its white-glove account management can also help organize follow-up, support employee advocacy, and explain managing pharmacy benefits. The employer still owns the final decision, supported by a clear record of costs, tradeoffs, and planned safeguards.

Frequently Asked Questions

How often do insurance companies change their formulary?

Health plans commonly review formularies before each plan year, but some changes can also occur midyear. Employers should request the proposed drug list and a change report before renewal. Compare removed drugs, tier moves, prior authorization rules, and covered alternatives against recent claims. This review helps identify employee disruption and budget effects before the new plan takes effect.

Why do insurance formularies change every year?

Formularies change as new drugs and generics enter the market, clinical guidance evolves, and medication prices shift. Plans and PBMs also revise coverage to manage spending while maintaining clinical value. An academic review of formulary systems describes formularies as established tools for managing pharmacy benefits. Employers should still examine whether each annual change transfers costs or access barriers to employees.

What should employees do if insurance stops covering a medication?

An employee whose medication loses coverage should contact the prescriber and the health plan or PBM before making any treatment change. They can ask about covered alternatives, prior authorization, a formulary exception, and the appeal process. Employers can support this process by sharing plan contacts, deadlines, and assistance resources while protecting the employee’s private health information.

How can employers manage prescription drug costs?

Employers can review de-identified pharmacy claims, compare plan spending with employee costs, and examine specialty drugs, exclusions, and tier changes. They should ask the PBM to explain pricing, rebates, utilization rules, and lower-cost clinical alternatives. Cost sharing also deserves review because the CDC found that higher out-of-pocket costs were associated with lower medication adherence.

Ready to review formulary changes before renewal?

Employers should start a formulary review early enough to compare drug-level changes, measure disruption, ask vendors follow-up questions, and prepare employee notices. A structured review helps HR and finance leaders make a defensible renewal decision while giving affected employees time to understand their options and support channels.

Delaying a formulary review until renewal deadlines approach can leave your leadership team with less time to compare options and prepare employees. Unexamined changes may also create avoidable budget pressure, difficult employee questions, and rushed decisions about the benefits your workforce depends on. Starting now gives your team time to identify concerns, weigh tradeoffs, and build a clear renewal strategy around cost predictability and employee access.

Ready to plan before renewal decisions become urgent? Request a plan review to talk with an unbiased Washington benefits advisor about your formulary and next steps. A focused conversation can help you organize the right questions and set a practical review timeline before your renewal window narrows.